Latest publication from the Wayne Harding research group at Hunter College provides integral information regarding the structural tolerance for the affinity of aporphines at serotonin and dopamine receptors. This fundamental knowledge could be key to the discovery and development of therapeutics for Parkinson’s disease, schizophrenia, and substance use disorders.
This entry is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International license.
